NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹7.87 Cr | ₹3.19 Cr | ₹3.28 Cr | ₹1.79 Cr | ₹1.32 Cr |
What is the latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹7.87 Cr |
Mar2023 | ₹3.19 Cr |
Mar2022 | ₹3.28 Cr |
Mar2013 | ₹1.79 Cr |
Mar2012 | ₹1.32 Cr |
How is Total Non-Current Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹7.87 Cr | 146.55 | |
Mar2023 | ₹3.19 Cr | -2.60 | |
Mar2022 | ₹3.28 Cr | 82.96 | |
Mar2013 | ₹1.79 Cr | 35.20 | |
Mar2012 | ₹1.32 Cr | - |
Compare Total Non-Current Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹302.1 Cr | -5.6% | 1.9% | -16.4% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,295.0 Cr | -0.8% | 6.7% | 26.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,349.6 Cr | -8.1% | 12.8% | 87.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,392.0 Cr | -1.6% | 1% | -2.2% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,429.6 Cr | -12.8% | 8.2% | -36.7% | Stock Analytics | |
INDO US BIOTECH | ₹340.9 Cr | -1.9% | 8.4% | -29.5% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -5.6% |
1.9% |
-16.4% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses